{"id":"https://openalex.org/W4245917312","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1560","title":"Abstract 1560: Selection of a bispecific trivalent HER2 x CD137 TRIDENT format providing optimal tumor-anchored immune co-stimulation","display_name":"Abstract 1560: Selection of a bispecific trivalent HER2 x CD137 TRIDENT format providing optimal tumor-anchored immune co-stimulation","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4245917312","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1560"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-1560","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1560","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-1560","pdf_url":null,"source":{"id":"https://openalex.org/S89865888","display_name":"Immunology","issn_l":"0019-2805","issn":["0019-2805","1365-2567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunology","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005053576","display_name":"Liqin Liu","orcid":"https://orcid.org/0000-0001-7158-6772","observed_orcids":["https://orcid.org/0000-0001-7158-6772","https://orcid.org/0000-0001-5436-1790","https://orcid.org/0009-0004-2886-3905"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liqin Liu","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074604187","display_name":"Chia\u2010Ying K. Lam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chia-Ying K. Lam","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110185766","display_name":"Ralph F. Alderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Alderson","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041233681","display_name":"Vatana Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vatana Long","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118788581","display_name":"Yinhua Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yinhua Yang","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Burns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Burns","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074909322","display_name":"Lusiana Widjaja","orcid":"https://orcid.org/0000-0002-6379-1415","observed_orcids":["https://orcid.org/0000-0002-6379-1415"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lusiana Widjaja","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jonathan Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Li","raw_affiliation_strings":["MacroGenics, Inc., Brisbane, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Brisbane, CA","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christina Wolf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Wolf","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061388073","display_name":"Valentina C. Ciccarone","orcid":"https://orcid.org/0000-0001-5530-7112","observed_orcids":["https://orcid.org/0000-0001-5530-7112"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valentina Ciccarone","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016101772","display_name":"James K. Tamura","orcid":"https://orcid.org/0000-0002-0463-2932","observed_orcids":["https://orcid.org/0000-0002-0463-2932"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Tamura","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003749078","display_name":"Gundo Diedrich","orcid":"https://orcid.org/0000-0001-5109-0307","observed_orcids":["https://orcid.org/0000-0001-5109-0307"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gundo Diedrich","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009027578","display_name":"Ezio Bonvini","orcid":"https://orcid.org/0000-0001-9054-3137","observed_orcids":["https://orcid.org/0000-0001-9054-3137"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ezio Bonvini","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031117799","display_name":"Syd Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syd Johnson","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023294934","display_name":"Paul A. Moore","orcid":"https://orcid.org/0000-0001-6057-7539","observed_orcids":["https://orcid.org/0000-0001-6057-7539"]},"institutions":[{"id":"https://openalex.org/I4210106297","display_name":"MacroGenics (United States)","ror":"https://ror.org/01hcd4187","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A. Moore","raw_affiliation_strings":["MacroGenics, Inc., Rockville, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MacroGenics, Inc., Rockville, MD","institution_ids":["https://openalex.org/I4210106297"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210106297"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1560","last_page":"1560"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0210999995470047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.5389999747276306},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.4410000145435333},{"id":"https://openalex.org/keywords/margetuximab","display_name":"margetuximab","score":0.7210000157356262},{"id":"https://openalex.org/keywords/b7-h3","display_name":"B7-H3","score":0.777999997138977},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.5189999938011169},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.4959999918937683},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C2780249625","wikidata":"https://www.wikidata.org/wiki/Q14913226","display_name":"CD137","level":4,"score":0.8028837442398071},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.49184513092041016},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4908495545387268},{"id":"https://openalex.org/C2777909563","wikidata":"https://www.wikidata.org/wiki/Q271628","display_name":"Trident","level":2,"score":0.4797895550727844},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43149319291114807},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.4265159070491791},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.40856778621673584},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.24421566724777222},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2327461838722229},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.13799265027046204},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12680068612098694},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11785560846328735},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.07644563913345337},{"id":"https://openalex.org/C74916050","wikidata":"https://www.wikidata.org/wiki/Q841090","display_name":"Classics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-1560","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1560","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-1560","pdf_url":null,"source":{"id":"https://openalex.org/S89865888","display_name":"Immunology","issn_l":"0019-2805","issn":["0019-2805","1365-2567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunology","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4251372154","https://openalex.org/W2741361137","https://openalex.org/W2405402424","https://openalex.org/W2490035279","https://openalex.org/W2157150174","https://openalex.org/W2400398928","https://openalex.org/W2327409939","https://openalex.org/W1561552618","https://openalex.org/W4247444352","https://openalex.org/W2547318564"],"abstract_inverted_index":{"Introduction:":[0],"CD137":[1,20,41,52,67,81,116,168,178,182,218,231,248,262,281,297,322,327,343,353,371,429],"(4-1BB)":[2],"signaling":[3,135],"provides":[4,47],"co-stimulation":[5,21,82,137,183,436],"of":[6,63,113,144,189,225,270,294,423,440],"CD8":[7,302],"or":[8,13,34,100,124,142],"NK":[9],"cells":[10,146,208,303],"following":[11],"antigen":[12],"Fc\u03b3R":[14],"engagement,":[15],"respectively.":[16],"Efforts":[17],"to":[18,43,50,54,75,109,299],"leverage":[19],"via":[22],"agonistic":[23],"monoclonal":[24],"antibodies":[25],"(mAbs)":[26],"have":[27,374],"been":[28],"thwarted":[29],"by":[30,240],"limited":[31],"clinical":[32],"efficacy":[33],"unacceptable":[35],"toxicity.":[36],"Bispecific":[37],"targeting":[38],"strategies":[39],"linking":[40],"activation":[42,53,219,328],"a":[44,61,84,103,111,272,307,330,337,359,364,379,424],"tumor-targeting":[45],"moiety":[46],"an":[48,242],"approach":[49],"localize":[51],"the":[55,77,140,187,223,266,292,441],"tumor":[56,145,207,227,308],"microenvironment.":[57],"Here":[58],"we":[59],"evaluate":[60],"panel":[62],"Fc-bearing":[64],"HER2":[65,114,171,190,195,199,229,260,295,320,346,351,369,427],"x":[66,115,230,261,274,296,321,352,370,428],"bispecific":[68,117,263,276,311,323,367,425],"molecules":[69,118,130,165,264,298,373],"incorporating":[70,383],"different":[71],"valency":[72],"and":[73,102,121,136,155,169,203,209,236,313,344,363,377],"geometry":[74],"define":[76],"format":[78,324,431],"providing":[79,325,432],"optimal":[80,174,319,433],"in":[83,119,133,139,153,156,222,267,287,329],"tumor-cell":[85,176],"anchor-dependent":[86],"manner.Methods:":[87],"An":[88,318],"anti-HER2":[89,244],"mAb":[90,106,245,362],"specificity":[91],"that":[92,246,279],"does":[93],"not":[94],"cross":[95],"compete":[96],"with":[97,161,186,194,212,253,306,350,357],"margetuximab,":[98,241],"trastuzumab":[99],"pertuzumab":[101],"proprietary":[104],"anti-CD137":[105],"were":[107,131,151],"utilized":[108],"assemble":[110],"set":[112],"bivalent":[120,167,342],"tetravalent":[122],"DART\u00ae":[123],"trivalent":[125,338,426],"TRIDENTTM":[126],"configurations.":[127],"The":[128],"resulting":[129],"compared":[132],"binding,":[134],"assays":[138],"presence":[141],"absence":[143,224],"expressing":[147],"HER2.":[148],"Combination":[149],"studies":[150,290],"performed":[152],"vitro":[154,268],"immune":[157,179,435],"deficient":[158],"mice":[159],"reconstituted":[160],"human":[162],"PBMCs.Results:":[163],"TRIDENT":[164,339,372,430],"bearing":[166,341],"monovalent":[170,345],"binding":[172],"achieve":[173],"HER2-dependent":[175],"anchored":[177],"cell":[180,215],"co-stimulation.":[181],"increases":[184],"proportionally":[185],"level":[188],"expression":[191,249],"as":[192,336],"observed":[193,221,356],"1+":[196],"(MCF7":[197],"breast),":[198],"2+":[200],"(JIMT1":[201],"breast)":[202],"3+":[204],"(N87":[205],"gastric)":[206],"was":[210,334,355],"paralleled":[211],"increased":[213],"HER2+/CD137+":[214],"association.":[216],"No":[217],"is":[220],"HER2-expressing":[226],"cells.":[228,258],"bispecifics":[232,354],"enhance":[233,315],"NK-cell":[234],"proliferation":[235],"IFN-\u03b3":[237],"release":[238],"induced":[239],"Fc-optimized":[243],"up-regulates":[247,280],"on":[250],"NK-cells":[251],"concomitant":[252],"enhanced":[254,265],"ADCC":[255],"against":[256],"HER2-positive":[257],"Similarly,":[259],"activity":[269,349],"orlotamab,":[271],"B7-H3":[273],"CD3":[275,310],"DART":[277],"molecule":[278,312,340],"during":[282],"T-cell":[283],"redirected":[284],"killing.":[285],"Finally,":[286],"vivo":[288],"mouse":[289],"demonstrate":[291],"ability":[293],"expand":[300],"tumor-associated":[301],"when":[304],"co-administered":[305],"targeted":[309],"support":[314],"anti-tumor":[316],"activity.Conclusion:":[317],"maximal":[326],"HER2-":[331],"dependent":[332],"manner":[333],"identified":[335],"binding.":[347],"Combinatorial":[348],"both":[358],"HER2-directed":[360],"therapeutic":[361,375],"CD3-engaging":[365],"tumor-targeted":[366],"molecule.":[368],"potential":[376],"provide":[378],"structural":[380],"template":[381],"for":[382,444],"alternate":[384],"tumor-":[385],"and/or":[386],"co-stimulatory-targeting":[387],"arms.Citation":[388],"Format:":[389],"Liqin":[390],"Liu,":[391],"Chia-Ying":[392],"K.":[393],"Lam,":[394],"Ralph":[395],"Alderson,":[396],"Vatana":[397],"Long,":[398],"Yinhua":[399],"Yang,":[400],"Robert":[401],"Burns,":[402],"Lusiana":[403],"Widjaja,":[404],"Jonathan":[405],"Li,":[406],"Christina":[407],"Wolf,":[408],"Valentina":[409],"Ciccarone,":[410],"James":[411],"Tamura,":[412],"Gundo":[413],"Diedrich,":[414],"Ezio":[415],"Bonvini,":[416],"Syd":[417],"Johnson,":[418],"Paul":[419],"A.":[420],"Moore.":[421],"Selection":[422],"tumor-anchored":[434],"[abstract].":[437],"In:":[438],"Proceedings":[439],"American":[442],"Association":[443],"Cancer":[445,459],"Research":[446],"Annual":[447],"Meeting":[448],"2019;":[449],"2019":[450],"Mar":[451],"29-Apr":[452],"3;":[453],"Atlanta,":[454],"GA.":[455],"Philadelphia":[456],"(PA):":[457],"AACR;":[458],"Res":[460],"2019;79(13":[461],"Suppl):Abstract":[462],"nr":[463],"1560.":[464]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-05-12T00:00:00"}